Home | Medical-Newswire.Com:
(Medical-NewsWire.com, April 07, 2021 ) Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.
The Global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.
Consumables accounted for the largest share of the market in 2019
The urinalysis market, based on product type, is segmented into consumables and instruments. The consumables segment dominated this market in 2019. The urinalysis consumables market is segmented into pregnancy & fertility kits, dipsticks, reagents, and disposables. Pregnancy and fertility kits accounted for the largest share of this market in 2019.
Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
Increasing use of urinalysis in disease screening in 2019
Based on application, the urinalysis market is segmented into disease screening and pregnancy and fertility. In 2019, the disease screening segment accounted for the largest market share owing to the fact that urine analysis has become a part of the general check-up in hospitals and clinics.
North America to grow at the highest rate during the forecast period (2019–2024)
The urinalysis systems market in North America is expected to grow at a rapid pace in the coming years. There has been a tremendous increase in the use of urine analysis and has become a part of any general health check up in the past decade. Increasing research activities in the field of urinalysis and growing awareness of personalized medicine have also resulted in the establishment point of care systems. Automated devices have also been installed in the large hospitals and laboratories.
Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294
Key Market Players
The major players operating in the urinalysis market are Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China).
In 2018, Beckman Coulter launched IQ Workcell 3000 and 2000.
In 2018, DIRUI Industrial Co. Ltd. Launched the FUS 1000 Automated Urine Analyzer.
In 2018, Beckman Coulter and Arkray formed a partnership to deliver integrated urine analyzers.
Mr. Aashish Mehra